BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

Zomedica Secures ISO 13485 Certification for Operational Enhancement

Zomedica Corp. has achieved ISO 13485:2016 certification for its facilities in Plymouth, Minnesota, and Roswell, Georgia. This certification underscores the company's commitment to quality and compliance. It enhances their global readiness and aligns with their long-term growth strategy. The ISO 13485 standard is pivotal in the medical device industry, covering aspects like design, production, and regulatory compliance.

The certification promises several advantages for Zomedica. It facilitates international market access and regulatory adherence, building customer confidence and credibility. Operational efficiency is expected to improve, reducing costs and waste while maintaining product quality. The certification also provides a platform for innovation, particularly in expanding product lines to human health markets.

As Zomedica continues to grow, the certification supports their infrastructure for future initiatives, including scaling their global presence. By securing this certification, the company solidifies its foundation for sustained market penetration and shareholder value enhancement.

R. H.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news